Conventional oncology is based on FDA approved therapies. And FDA approved therapies are based on clinical trials- usually of large groups. Meso is a rare cancer affecting approximately 3000 people annually.
My point is that conventional oncology really doesn’t know much about meso. Nothing against oncologists, they just have little experience to go on.
A seemly simple issue of whether to have tradition before or after surgery should be a straightforward decision. But it is not in meso treatment. As the studies linked and excerpted below explain, radiation before surgery is twice as effective, on average, as radiation after surgery.
I am a long-term survivor of a different cancer. I was told that my cancer was incurable. That was back in 1994 when I was diagnosed. After several years of aggressive conventional oncology and “we can do nothing more for you” I took control of my health and researched evidence-based, non-toxic, anti-cancer therapies.
Mesothelioma is considered to be incurable by conventional oncology. There are evidence-based, non-conventional therapies for meso patients to learn about and consider.
For more information about mesothelioma therapies- both conventional and non-conventional, scroll down the page, post a question or comment and I will reply ASAP.
“Results of clinical research that treated mesothelioma with radiation before surgery show the three-year survival rate more than doubled for study participants afflicted with this deadly disease, compared to treating with surgery first…“The patients in our study experienced shorter treatment, fewer complications and speedier recovery,” says Dr. Cho. “The three-year survival rate more than doubled to 72% from 32%.”
Participants were treated with an accelerated, five-day course of intensity-modulated radiation therapy (IMRT), a specialized technique that conforms the radiation dose around the tumours in 3D while sparing the heart, spine and other healthy tissues. The patients underwent surgery to remove the affected lung the following week…”
“Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival…“